Inventure
VC Fund
Helsinki, Finland
Inventure is a VC fund in Helsinki focused on Software and Information Technology. We commit to early-stage founders with roots in the Nordics and Baltics. Those we back are in. We believe in them fully, fight for them fiercely, and build lasting trust that goes both ways. We back the few—because they’re the ones who can build futures others can’t imagine and improve life for the many.
- Total investments:
- 176
- Last investment:
- Lead investor:
- 48%
- Fund size:
- $169M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Inventure invests in
Stages Inventure invests in
Countries Inventure invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $549k–$5.9M
- Series A
- $1.3M–$17M
- Series B
- $1.3M–$25M
Investment Focus
Industry
- Software 29 (16%)
- Information Technology 16 (9%)
- Health Care 13 (7%)
- Artificial Intelligence 12 (7%)
- Mobile 11 (6%)
Stage
- Seed 57 (32%)
- Series A 44 (25%)
- Series B 12 (7%)
- Funding Round 12 (7%)
- Pre-Seed 10 (6%)
Country
- Finland 45 (26%)
- Sweden 19 (11%)
- United States 8 (5%)
- Denmark 5 (3%)
- United Kingdom 5 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Fei Xu
Operations Director
|
Operations Director | Total investments: 0 | Find email | |
Andrea Di Pietrantonio
Portfolio Operations Director
|
Portfolio Operations Director | Total investments: 0 | Find email | |
Daniela Bensky
Employee Experience Manager
|
Employee Experience Manager | Total investments: 0 | Find email | |
Kevin Lösch
Investment Associate
|
Investment Associate | Total investments: 4 | Find email | |
Lauri Kokkila
Partner
|
Partner | Total investments: 6 | Find email | |
| See all 9 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Algorithmiq
|
Algorithmiq utilizes its expertise in quantum information, complex systems, and computational physics to develop algorithms to develop new and effective drugs, solve problems in life sciences, and discover new materials. | $21.2M / Venture - Series Unknown / May 11, 2026 | |
Lassie
|
Lassie is the first proactive and preventive pet insurance company that wants to help pet owners take better care of their pets | $75M / Series C / Feb 12, 2026 | |
|
Capalo AI
|
Capalo AI offers a state-of-the-art Artificial Intelligence platform for the energy industry. | $13M / Series A / Feb 06, 2026 | |
Avenue Biosciences
|
Avenue Biosciences is a transatlantic biotechnology company committed to speeding up the research and development of protein biologics and tools for the biotechnology industry, ensuring that no lifesaving therapy goes unmet due to production constraints. | $7.4M / Seed / Jan 12, 2026 | |
Encube Technologies
|
Encube Technologies operates as a visual collaboration platform where hardware teams come together to explore designs, share insights and shape ideas. | $23M / Series A / Oct 16, 2025 | |
ReOrbit
|
Founded in 2019 and headquartered in Helsinki, Finland, ReOrbit is a fast-growing European space technology company that manufactures sovereign satellites and connected systems for national security. Our technologies provide independent control of critical space assets and enable secure communications for both military and civilian use. Throughlong-term partnerships and knowledge transfer, we ensure our customers achieve and maintain strategic autonomy.With offices across multiple countries, we bring together a diverse team of experts who bring extensive industry experience and technical excellence to our operations. As we continue to expand, we are opening new locations worldwide and are always on the lookout for talented, ambitious individuals to join our journey. | $53M / Series A / Sep 08, 2025 | |
Hamina Wireless
|
Hamina Wireless is a tool for designing wireless networks, from Wi-Fi 6E to 4G, 5G, BLE, Zigbee, and more. | Seed / Jul 18, 2025 | |
Samphire Neuroscience
|
Samphire Neuroscience builds clinically validated neurotechnology to support women across their lives. Our wearable devices, Nettle™ and Lutea™, are built on the same underlying brain-stimulation technology, targeting neural pathways involved in pain, mood, stress, and sleep regulation. - Lutea™ is available globally as a wellness device. Itstimulates the same regions of the brain to support stress regulation, sleep, and recovery - key drivers of readiness and long-term performance - allowing athletes and teams to move beyond wellbeing education alone to practical, evidence-based intervention. - Nettle™ is a CE-marked (EU and UK regulated), drug- and hormone-free device that has been clinically shown to improve pain, mood, functionality, and the ability to train during the menstrual cycle, with measurable benefits after one month of use - supporting athletes to maintain training intensity and movement quality during their period. - The Samphire App is the platform controlling all Samphire hardware products with the use of CycleSync™ AI technology: the only one of its kind to support personalized neurotechnology use for women. | $5M / Seed / Jun 03, 2025 | |
Hedera Dx
|
With the use of Hedera Dx's liquid biopsy solution, hospital labs will be able to conduct clinically useful liquid biopsies on their own. This will greatly simplify tumor profiling. It is difficult to accomplish IVD compliance, privacy infrastructure, and validation, and even if these challenges are overcome, the current software workflows areinefficient to use and lack key capabilities.Hedera Dx was established on July 1, 2021 in Epalinges, Vaud. | $17M / Series A / May 27, 2025 | |
|
Capalo AI
|
Capalo AI offers a state-of-the-art Artificial Intelligence platform for the energy industry. | $4.1M / Seed / Mar 19, 2025 | |
| See all 176 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Inventure invest in?
Inventure invests primarily in Software, Information Technology and Health Care startups, most often at Seed and Series A stage. Most of the 176 investments tracked by Shizune back companies in Finland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Inventure's check size?
Inventure typically joins rounds of $549k–$5.9M at Seed, $1.3M–$17M at Series A and $1.3M–$25M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Inventure participates in.
How do I contact Inventure?
Public channels for Inventure include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Inventure?
The team at Inventure includes Fei Xu (Operations Director), Andrea Di Pietrantonio (Portfolio Operations Director) and Daniela Bensky (Employee Experience Manager), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
